Clinical Development
Question Based Clinical Development facilitates the design of a rational and efficient development pathway for new medical interventions. Learn the principles behind QBCD and how to apply it to real R&D projects.
Subscribe now or read more about this module below
Subscribe today
Download the Clinical Development brochure
Download brochure
Clinical Development Online
standalone or part of the blended course package
Want to have a look at the way we teach online?
Learn how to use the QBCD approach to formulate key questions when developing a new medical intervention
Learn how to deal optimally with development risks and costs
Learn how to work with the QBCD software program
Discuss online with peers and receive feedback from your course instructor
Clinical Development On-campus
prerequisite: online course
Everything from
Online +
Experience the challenge of decision making on R&D projects
Learn from the successes and failures of real-world R&D projects
Learn from your group members in small, interdisciplinary working groups
Hear about first-hand experiences from industry experts
Learn more below or sign-up for this course directly
One module, different options
The best way to experience our modules is to follow the blended route. The online course acts as a prerquisite for the on-campus part.
This module scores 82%
Scholarship
Scholarships are available for our courses. Read more about current scholarships and how to apply.
Read more
We understand if you want to have a look at this course. Login or create an account to access a free demo of the online course.
A confirmation email will be sent to new registrations. After completion, you're able to acces the online demo.
This 4-day on-campus course is held in beautiful Castle Oud Poelgeest near Leiden in the Netherlands. Participants who have successfully completed the online course are eligible for the on-campus course. Note that registration for the on-campus course includes the online course.
During the on-campus course, you will work in small groups on teaching cases based on real-world R&D projects. You will also meet peers and contributors from academia and leading life-sciences companies.
What makes this course special?
The on-campus course builds upon the principles of Questions Based Clinical Development (QBCD) that you learned in the online course. Preparation for the on-campus course involves approximately 20-30 hours studying the advanced teaching cases and completing individual pre-course assignments. You will then be prepared for the on-campus course in which you will work in small groups on assignments related to the teaching cases. As the “development team”, you and your group will make informed choices as you develop the product described in the teaching case. You will also present your proposal to a mock development board and/or regulatory agency representatives. Importantly, the teaching cases are based on real-world R&D projects and were developed in close collaboration with many who were actually involved in the original projects. Representatives from these companies will join us on campus to share their experiences and explain what really happened. Each year, a maximum of 25 participants are accepted to the on-campus course, ensuring a rich learning environment with highly focused discussions.
What will you learn?
During this intensive 4-day course, you will dive head-first into a number of advanced teaching cases. Each day, you will discuss
5 things you will take away from this course
During this course, you will:
- Experience the challenge of decision making on R&D projects
- Learn from the successes and failures of real-world R&D projects;
- Work in small, highly interactive interdisciplinary groups;
- Hear about first-hand experiences from industry experts.

This course receives a 9.5 from participants
Address
Kasteel Oud Poelgeest B.V., Poelgeesterweg, Oegstgeest, NetherlandsView on Google Maps
I know enough, let's
Clinical Development contributors
On-campus

Nacer Lounis
Senior Principal Scientist
Janssen Pharmaceutica
On-campus

Tine de Marez
Senior Director, Compound Development Team Leader TB
Johnson & Johnson
On-campus

Erik Niks
Neurologist - Pediatric neurologist
Leiden University Medical Center
On-campus

Piet Hinoul
Global Head, Pre-Clinical, Clinical and Medical Affairs
J&J Ethicon
On-campus

Ad Sitsen
Owner
ClinPharMed Consultancy for Drug Development

Paul Stoffels
Chief scientific officer
Johnson & Johnson

Tom Huizinga
Head of the Department of Rheumatology
Leiden University Medical Centre
On-campus

Marcel Kenter
Director
Paul Janssen Futurelab Leiden
On-campus

Koen Andries
VP Scientific Fellow Infectious Diseases Discovery
Janssen Pharmaceutica NV
On-campus

Andreas Wallnöfer
General Partner
BioMed Partners Venture Capital (former Head of Clinical Research & Exploratory Development at F. Hoffmann-La Roche Ltd.)
On-campus

Justin Hay
Pharmacokinetics Assessor
Medicines and Healthcare products Regulatory Agency
On-campus

André Elferink
Clinical epidemiologist
Dutch Medicines Evaluation Board
On-campus

Rob Zuiker
Senior Clinical Scientist
CHDR

Hans-Georg Eichler
Senior Medical Officer
European Medicines Agency
On-campus

Robert Klautz
Thoracic Surgeon
Leiden University Medical Centre
On-campus

Matthijs Moerland
Research Director Translational Biomarkers
CHDR

Joris Rotmans, MD, PhD
internist-nephrologist
LUMC
On-campus

Janneke Meulenberg
CEO
Arthrogen

Inge de Lepeleire
Director Translational Pharmacology
MSD Europe
On-campus

Koos Burggraaf
Research Director CVS & Metabolism
CHDR

Johan Garssen
Director Immunology Platform
Danone/Nutricia Research
On-campus

Ingrid de Visser
Senior Clinical Scientist
CHDR

Rick Kuntz
Senior Vice President and Chief Scientific, Clinical and Regulatory Officer
Medtronic
On-campus

Geert Jan Groeneveld
Research Director CNS
CHDR

Oliver Bisazza
Director Regulatory Policy
Medtronic

Saco de Visser
Teacher and Clinical Pharmacologist
Paul Janssen Futurelab Leiden
On-campus

Adam Cohen
CEO and clinical pharmacologist
Centre for Human Drug Research

Richard Shull
Head of Deal Structuring and Trading Fundamentals
Shell

Pierre Peeters
Former site head early stage development
Organon